Literature DB >> 32706621

Multidrug-Resistant Hospital Bacteria: Epidemiological Factors and Susceptibility Profile.

Marisa Castro Jara1,2, Andressa Vieira Frediani2, Fabiane Knepper Zehetmeyer1, Fábio Raphael Pascoti Bruhn3, Milene Ribeiro Müller4, Róger Giusti Miller4, Patrícia da Silva Nascente1,2.   

Abstract

Increase in antimicrobial resistance to antibiotics is the product of the evolution and natural adaptation of microorganisms through mutations and genetic recombination caused by the indiscriminate use of antibiotics and the ineffective control and prevention of infection. The current study analyzes the profile of multiresistant hospital bacteria in two hospitals in Pelotas, state of Rio Grande do Sul, Brazil. Over the course of 4 months, patient's gender and age, hospital accommodation type, and sample site were evaluated. Two hundred and eighty-six microbiological culture antibiogram reports of hospitalized patients and outpatients of both sexes, between zero and 96 years of age, were analyzed. Bacterium Klebsiella pneumoniae was the most prevalent. The most resistant Gram-negative bacilli (GNB) were K. pneumoniae (27.5%); Acinetobacter baumannii (24.1%); Escherichia coli (14.7%); and Pseudomonas aeruginosa (14.5%). The most resistant Gram-positive cocci (GPC) were Enterococcus faecium (27.5%) and Staphylococcus aureus (25.5%). The classes of antibiotics with the greatest number of resistant GNB included penicillins (84.8%), quinolones (77.5%), and cephalosporins (75.7%). In the case of GPC, the most resistant were macrolides (95.4%); lincosamides (90.3%), and penicillins (77%). Among GNBs, polypeptides had the highest sensitivity rate (81.3%), whereas, among GPC, fusidanes, glycylcyclines, and lipopeptides had 100% sensitivity.

Entities:  

Keywords:  MDR; antibiotics; epidemiology; hospital infection; infections related to health assistance

Year:  2020        PMID: 32706621     DOI: 10.1089/mdr.2019.0209

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  2 in total

1.  Dihydropyrimidinones Against Multiresistant Bacteria.

Authors:  Marisa Castro Jara; Allison Carlos Assunção Silva; Marina Ritter; Adriana Fernandes da Silva; Carolina Lambrecht Gonçalves; Pedro Rassier Dos Santos; Luciano Sisconetto Borja; Cláudio Martin Pereira de Pereira; Patrícia da Silva Nascente
Journal:  Front Microbiol       Date:  2022-03-18       Impact factor: 5.640

2.  Large-Scale Studies on Antimicrobial Resistance and Molecular Characterization of Escherichia coli from Food Animals in Developed Areas of Eastern China.

Authors:  Jiangang Ma; Wei Zhou; Jing Wu; Xiaofeng Liu; Jiahui Lin; Xiaofeng Ji; Hui Lin; Jianmei Wang; Han Jiang; Qianjin Zhou; Guoping Zhao; Hua Yang; Biao Tang
Journal:  Microbiol Spectr       Date:  2022-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.